Monte Rosa Therapeutics GLUE
NASDAQ GLUE
$10.50 -0.76 (-6.75%)
At close: Oct 2, 2026 · 4:00 PM EDT

Monte Rosa Therapeutics (GLUE) Cash & Current Investments (2020 - 2026)

Updated

Monte Rosa Therapeutics' Cash & Current Investments came in at $90.1 million for Q2 2026, up 29.8% from $69.43 million a year earlier but down 43.6% from the prior quarter.

Analysis

Monte Rosa Therapeutics (GLUE) Cash & Current Investments (2020 - 2026) Analysis & Trends

At the end of FY2025, Monte Rosa Therapeutics' Cash & Current Investments was $129.88 million, down 42.1% from FY2024.

  • Cash & Current Investments carries a five-year compound annual growth rate of 25.5% (FY2020 to FY2025).
  • Going back by year, Cash & Current Investments was $224.25 million in FY2024 (+75.1%), $128.1 million in FY2023 (+133.3%), $54.91 million in FY2022 (-84.1%) and $346.07 million in FY2021 (+729.9%).
  • The five-year range for quarterly Cash & Current Investments is $47.03 million (Q2 2023) to $367.03 million (Q3 2021).
  • Year-over-year, Cash & Current Investments increased in five of the last eight quarters, with growth averaging 35.9%.
  • The fastest year-over-year change in Cash & Current Investments over five years came in Q4 2021 (growth of 729.9%), and the weakest in Q4 2022 (a decline of 84.1%).
  • Business Quant data shows GLUE's Cash & Current Investments at $159.86 million (Q1 2026), $129.88 million (Q4 2025) and $208.34 million (Q3 2025) in the three quarters before Q2 2026.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash & Current Investments (Qtr)
1 Eli Lilly 1,076.25 Bn 1,044.84 Bn 19.71 Bn 8.95 Bn
2 Johnson & Johnson 617.18 Bn 535.70 Bn 17.26 Bn 20.76 Bn
3 AbbVie 464.58 Bn 437.73 Bn 12.70 Bn 6.57 Bn
4 Merck 356.04 Bn 310.47 Bn 12.21 Bn 7.14 Bn
5 Novartis Ag 269.07 Bn 224.94 Bn 11.24 Bn 9.92 Bn
6 Astrazeneca 243.21 Bn 216.77 Bn 12.86 Bn 4.97 Bn
7 Amgen 217.88 Bn 173.28 Bn 7.24 Bn 13.99 Bn
8 Gilead Sciences 179.62 Bn 153.74 Bn 6.22 Bn 3.18 Bn
9 Pfizer 158.45 Bn 105.40 Bn 10.94 Bn 11.70 Bn
10 Monte Rosa Therapeutics 894.88 Mn 306.69 Mn - 90.10 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 90.10 Mn
Mar 31, 2026 159.86 Mn
Dec 31, 2025 129.88 Mn
Sep 30, 2025 208.34 Mn
Jun 30, 2025 69.43 Mn
Mar 31, 2025 78.53 Mn
Dec 31, 2024 224.25 Mn
Sep 30, 2024 125.58 Mn
Jun 30, 2024 108.85 Mn
Mar 31, 2024 99.75 Mn
Dec 31, 2023 128.10 Mn
Sep 30, 2023 59.06 Mn
Jun 30, 2023 47.03 Mn
Mar 31, 2023 51.85 Mn
Dec 31, 2022 54.91 Mn
Sep 30, 2022 112.39 Mn
Jun 30, 2022 103.66 Mn
Mar 31, 2022 138.31 Mn
Dec 31, 2021 346.07 Mn
Sep 30, 2021 367.03 Mn
API Access

Monte Rosa Therapeutics Cash & Current Investments API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=cash-and-current-investments&ticker=GLUE&period=max&api_key=YOUR_API_KEY